Dental Diagnostic & Surgical Equipment Market by Type (Diagnostic, Surgical), Technology (Cad Cam Systems, Imaging Systems, Laser Systems), Modality, End User, Distribution Channel - Global Forecast 2025-2032
Description
The Dental Diagnostic & Surgical Equipment Market was valued at USD 9.14 billion in 2024 and is projected to grow to USD 9.85 billion in 2025, with a CAGR of 8.51%, reaching USD 17.57 billion by 2032.
An authoritative introduction outlining how integrated imaging, minimally invasive technologies, and workflow-centric design are redefining dental care delivery
Modern dental practice is being reshaped by the convergence of imaging precision, minimally invasive surgical systems, and digital workflow integration. Clinicians now expect tools that not only enhance diagnostic clarity but also integrate with chairside and laboratory processes to support predictable outcomes. Concurrently, healthcare administrators prioritize devices that reduce procedure time, lower maintenance complexity, and align with broader institutional investment strategies.
Against this background, manufacturers and distributors are investing in interoperability, ergonomic design, and usability studies to reduce learning curves and improve adoption. Technology development is increasingly user-driven, informed by clinician feedback loops and cross-disciplinary collaboration between oral surgeons, radiologists, and restorative dentists. In this environment, strategic decisions hinge on understanding not only product capabilities but also how devices fit into evolving clinical pathways and facility-level priorities.
A detailed exploration of the major technological and commercial shifts reshaping dental diagnostics and surgical equipment adoption across clinical practice
The dental equipment landscape is undergoing transformative shifts driven by technological maturation and changing care models. High-resolution three-dimensional imaging is moving from optional upgrade to essential diagnostic capability, enabling more precise treatment planning and facilitating collaboration across specialties. Simultaneously, advances in surgical platforms such as piezoelectric and laser systems are broadening the scope of procedures that can be performed with reduced trauma and faster recovery times.
In parallel, digital restorative workflows anchored by CAD/CAM systems are shortening treatment timelines and shifting fabrication from centralized labs toward more chairside solutions. Distribution and procurement channels are also evolving, with online platforms augmenting traditional hospital and direct sales relationships, and manufacturers offering service bundles and subscription models to reduce upfront capital barriers. These shifts create new competitive dynamics in which product ecosystem compatibility, software support, and post-sale service become decisive factors for adoption.
An analytical review of how 2025 United States tariffs have reshaped sourcing, pricing dynamics, and supplier strategies across the dental equipment value chain
The tariff environment introduced by the United States in 2025 has created a complex set of pressures across the dental equipment supply chain, affecting sourcing strategies, pricing structures, and supplier selection. For manufacturers that rely on internationally sourced components or finished products, tariffs have increased the effective landed cost of equipment, prompting many firms to revisit supplier footprints and to accelerate discussions about nearshoring and local assembly. These supply-chain recalibrations are altering lead times and inventory policies, and in certain cases driving product redesigns to minimize tariff exposure.
Moreover, distributors and end users have felt downstream effects in procurement negotiations and budget planning. Public and private purchasers have responded by placing greater emphasis on total cost of ownership and service agreements rather than purely headline acquisition cost. Simultaneously, some vendors have absorbed tariff-related costs to preserve market position, while others have restructured pricing tiers or introduced alternative lower-cost product lines. Consequently, the tariff policy has magnified the importance of flexible sourcing, clear cost transparency, and robust supplier relationship management across the dental equipment ecosystem.
Comprehensive segmentation intelligence synthesizing product types, end-user environments, technology platforms, distribution channels, and device modality distinctions
Understanding market behavior requires a granular look at product types, end-user settings, technology platforms, distribution pathways, and device modalities. On the product front, the landscape is divided between diagnostic and surgical equipment; diagnostic offerings encompass cone beam computed tomography systems, intraoral cameras, ultrasound devices, and traditional X-ray imaging systems, while surgical solutions include electrosurgical units, laser platforms, piezoelectric systems, and a variety of rotary instruments. These product groupings reflect distinct clinical use cases and regulatory pathways, and they demand different after-sales support structures.
End users span from ambulatory surgical centers and dental clinics to larger dental hospitals and specialty clinics, each with unique procurement cycles, capital constraints, and clinical priorities. Technology segmentation highlights the cross-cutting role of CAD/CAM, imaging, laser, and ultrasonic systems, with CAD/CAM subdivided into chairside and lab-based solutions and lasers differentiated into CO2, diode, and erbium types, while imaging systems and ultrasonic systems contain subcategories aligned to diagnostic and procedural use. Distribution channels range from direct sales and hospital distributors to online platforms, the latter including manufacturer websites and third-party e-commerce, which are changing purchase behaviors and expectations around delivery and service. Finally, modality distinctions between portable and stationary devices-where portable includes handheld devices and mobile trolley systems and stationary covers floor-mounted and tabletop systems-frame deployment decisions tied to space, patient throughput, and procedure mix. Taken together, these segmentation dimensions provide a framework for understanding buyer preferences, adoption barriers, and product development priorities across clinical settings.
Insightful regional analysis that compares adoption drivers, procurement behaviors, and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific
Regional dynamics in the dental equipment market reflect differences in healthcare infrastructure, reimbursement frameworks, and clinician training pathways. In the Americas, advanced reimbursement models in certain markets and a concentration of private dental practices have fostered demand for high-end imaging and chairside restorative solutions, while healthcare systems emphasize efficiency and equipment interoperability. In contrast, countries within Europe, the Middle East, and Africa present heterogeneous conditions where adoption varies widely: parts of Western Europe show strong integration of minimally invasive surgical systems and digital dentistry, whereas emerging markets across the Middle East and Africa often prioritize cost-effective, durable solutions with scalable service models.
Asia-Pacific exhibits a dual dynamic of rapid technology adoption in metropolitan referral centers alongside large addressable demand for portable and lower-cost systems in under-resourced areas. Regional manufacturing bases and supply-chain networks in Asia-Pacific have also influenced global sourcing patterns and competitive positioning. Across all regions, cross-border regulatory harmonization efforts and regional supplier partnerships continue to shape product launches and service footprints, making regional strategy an essential component of market entry and commercialization plans.
Critical insights into competitive behavior, product innovation trajectories, and service-led differentiation strategies among leading industry participants
Key industry participants are aligning their strategies around modular systems, service-led business models, and software-enabled value propositions. Leading original equipment manufacturers are investing in interoperable imaging and restorative platforms that facilitate cross-specialty workflows and reduce training friction. At the same time, smaller innovators are focusing on niche differentiation such as portable diagnostic tools, specialized laser modalities, or single-use surgical disposables that meet infection-control priorities.
Competitive dynamics are influenced by after-sales service capabilities, regulatory approvals, and strategic partnerships with clinical institutions. Companies that can offer bundled packages-combining device hardware, software updates, training, and preventive maintenance-tend to strengthen procurement relationships and reduce churn. New entrants are pursuing collaborative development with clinical leaders to validate clinical outcomes and accelerate adoption, while established vendors are leveraging scale to extend distribution networks and reduce time-to-service. Across the board, intellectual property around imaging algorithms, device ergonomics, and consumable interfaces remains a key differentiator shaping R&D investment decisions.
Actionable recommendations for manufacturers, distributors, and healthcare providers to strengthen interoperability, supply resilience, and service-based commercial models
Industry leaders should prioritize interoperability, clinician-centered design, and resilient sourcing to capture value in evolving clinical markets. Investing in open architecture platforms and standardized data exchange capabilities will reduce integration friction for purchasers and increase the perceived lifetime value of devices. At the same time, product development should be informed by iterative clinical validation studies that demonstrate not only technical performance but also workflow efficiency and patient-centric outcomes.
From an operational perspective, diversifying component suppliers and expanding regional assembly options can mitigate tariff and logistics risks while shortening lead times. Commercial teams should consider expanding service contracts and subscription models to shift procurement conversations from capital expenditure toward predictable operating expense frameworks. Finally, cultivating partnerships with training institutions and specialty clinics will accelerate clinician familiarity with new technologies and foster advocacy that supports broader adoption. These strategic moves will better equip organizations to navigate regulatory complexity, procurement scrutiny, and evolving clinician expectations.
A clear description of the multi-method research methodology combining primary clinician interviews, device usability assessments, secondary regulatory and supply-chain analysis, and triangulation
The research underpinning this analysis combined qualitative and quantitative methods to ensure a robust and triangulated perspective. Primary inputs included structured interviews with clinical end users across ambulatory surgical centers, dental clinics, hospitals, and specialty clinics; executive-level discussions with manufacturers and distributors; and hands-on usability assessments of diagnostic and surgical devices. These engagements provided insight into device performance, workflow integration, and post-sale support realities.
Secondary research encompassed peer-reviewed clinical literature, regulatory filings, product manuals, and publicly available procurement policies to construct a comprehensive view of technological capabilities and adoption constraints. Supply-chain mapping was performed using trade flow data and vendor disclosures to assess sourcing dependencies and tariff exposure. Wherever possible, findings were validated through multiple independent sources and cross-checked with clinician feedback to ensure practical relevance and factual accuracy. This layered methodology supports conclusions grounded in observed practice rather than speculative assumptions.
Concluding synthesis that ties technological innovation, commercial responses, and supply-chain dynamics into a cohesive outlook for dental diagnostics and surgical equipment
The trajectory of dental diagnostic and surgical equipment is defined by a convergence of precision imaging, minimally invasive procedural platforms, and digital restorative workflows that collectively improve clinical decision-making and patient experience. Technological advances are enabling clinicians to deliver more predictable outcomes with streamlined processes, while commercial and regulatory dynamics are reshaping how products are sourced, serviced, and financed. Stakeholders who adapt to these trends by prioritizing interoperability, flexible procurement options, and clinician education will be better positioned to translate innovation into routine practice.
Looking ahead, sustained attention to supply-chain resilience, user-driven product design, and service-oriented commercial models will determine which organizations emerge as preferred partners for healthcare providers. The combined influences of regional variability, tariff-driven sourcing realignments, and rapid technology iteration underscore the need for strategic agility and evidence-based product positioning. In sum, informed investment in the right mix of technology, service, and regional strategy will be decisive for entities seeking to lead in dental diagnostics and surgery.
Note: PDF & Excel + Online Access - 1 Year
An authoritative introduction outlining how integrated imaging, minimally invasive technologies, and workflow-centric design are redefining dental care delivery
Modern dental practice is being reshaped by the convergence of imaging precision, minimally invasive surgical systems, and digital workflow integration. Clinicians now expect tools that not only enhance diagnostic clarity but also integrate with chairside and laboratory processes to support predictable outcomes. Concurrently, healthcare administrators prioritize devices that reduce procedure time, lower maintenance complexity, and align with broader institutional investment strategies.
Against this background, manufacturers and distributors are investing in interoperability, ergonomic design, and usability studies to reduce learning curves and improve adoption. Technology development is increasingly user-driven, informed by clinician feedback loops and cross-disciplinary collaboration between oral surgeons, radiologists, and restorative dentists. In this environment, strategic decisions hinge on understanding not only product capabilities but also how devices fit into evolving clinical pathways and facility-level priorities.
A detailed exploration of the major technological and commercial shifts reshaping dental diagnostics and surgical equipment adoption across clinical practice
The dental equipment landscape is undergoing transformative shifts driven by technological maturation and changing care models. High-resolution three-dimensional imaging is moving from optional upgrade to essential diagnostic capability, enabling more precise treatment planning and facilitating collaboration across specialties. Simultaneously, advances in surgical platforms such as piezoelectric and laser systems are broadening the scope of procedures that can be performed with reduced trauma and faster recovery times.
In parallel, digital restorative workflows anchored by CAD/CAM systems are shortening treatment timelines and shifting fabrication from centralized labs toward more chairside solutions. Distribution and procurement channels are also evolving, with online platforms augmenting traditional hospital and direct sales relationships, and manufacturers offering service bundles and subscription models to reduce upfront capital barriers. These shifts create new competitive dynamics in which product ecosystem compatibility, software support, and post-sale service become decisive factors for adoption.
An analytical review of how 2025 United States tariffs have reshaped sourcing, pricing dynamics, and supplier strategies across the dental equipment value chain
The tariff environment introduced by the United States in 2025 has created a complex set of pressures across the dental equipment supply chain, affecting sourcing strategies, pricing structures, and supplier selection. For manufacturers that rely on internationally sourced components or finished products, tariffs have increased the effective landed cost of equipment, prompting many firms to revisit supplier footprints and to accelerate discussions about nearshoring and local assembly. These supply-chain recalibrations are altering lead times and inventory policies, and in certain cases driving product redesigns to minimize tariff exposure.
Moreover, distributors and end users have felt downstream effects in procurement negotiations and budget planning. Public and private purchasers have responded by placing greater emphasis on total cost of ownership and service agreements rather than purely headline acquisition cost. Simultaneously, some vendors have absorbed tariff-related costs to preserve market position, while others have restructured pricing tiers or introduced alternative lower-cost product lines. Consequently, the tariff policy has magnified the importance of flexible sourcing, clear cost transparency, and robust supplier relationship management across the dental equipment ecosystem.
Comprehensive segmentation intelligence synthesizing product types, end-user environments, technology platforms, distribution channels, and device modality distinctions
Understanding market behavior requires a granular look at product types, end-user settings, technology platforms, distribution pathways, and device modalities. On the product front, the landscape is divided between diagnostic and surgical equipment; diagnostic offerings encompass cone beam computed tomography systems, intraoral cameras, ultrasound devices, and traditional X-ray imaging systems, while surgical solutions include electrosurgical units, laser platforms, piezoelectric systems, and a variety of rotary instruments. These product groupings reflect distinct clinical use cases and regulatory pathways, and they demand different after-sales support structures.
End users span from ambulatory surgical centers and dental clinics to larger dental hospitals and specialty clinics, each with unique procurement cycles, capital constraints, and clinical priorities. Technology segmentation highlights the cross-cutting role of CAD/CAM, imaging, laser, and ultrasonic systems, with CAD/CAM subdivided into chairside and lab-based solutions and lasers differentiated into CO2, diode, and erbium types, while imaging systems and ultrasonic systems contain subcategories aligned to diagnostic and procedural use. Distribution channels range from direct sales and hospital distributors to online platforms, the latter including manufacturer websites and third-party e-commerce, which are changing purchase behaviors and expectations around delivery and service. Finally, modality distinctions between portable and stationary devices-where portable includes handheld devices and mobile trolley systems and stationary covers floor-mounted and tabletop systems-frame deployment decisions tied to space, patient throughput, and procedure mix. Taken together, these segmentation dimensions provide a framework for understanding buyer preferences, adoption barriers, and product development priorities across clinical settings.
Insightful regional analysis that compares adoption drivers, procurement behaviors, and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific
Regional dynamics in the dental equipment market reflect differences in healthcare infrastructure, reimbursement frameworks, and clinician training pathways. In the Americas, advanced reimbursement models in certain markets and a concentration of private dental practices have fostered demand for high-end imaging and chairside restorative solutions, while healthcare systems emphasize efficiency and equipment interoperability. In contrast, countries within Europe, the Middle East, and Africa present heterogeneous conditions where adoption varies widely: parts of Western Europe show strong integration of minimally invasive surgical systems and digital dentistry, whereas emerging markets across the Middle East and Africa often prioritize cost-effective, durable solutions with scalable service models.
Asia-Pacific exhibits a dual dynamic of rapid technology adoption in metropolitan referral centers alongside large addressable demand for portable and lower-cost systems in under-resourced areas. Regional manufacturing bases and supply-chain networks in Asia-Pacific have also influenced global sourcing patterns and competitive positioning. Across all regions, cross-border regulatory harmonization efforts and regional supplier partnerships continue to shape product launches and service footprints, making regional strategy an essential component of market entry and commercialization plans.
Critical insights into competitive behavior, product innovation trajectories, and service-led differentiation strategies among leading industry participants
Key industry participants are aligning their strategies around modular systems, service-led business models, and software-enabled value propositions. Leading original equipment manufacturers are investing in interoperable imaging and restorative platforms that facilitate cross-specialty workflows and reduce training friction. At the same time, smaller innovators are focusing on niche differentiation such as portable diagnostic tools, specialized laser modalities, or single-use surgical disposables that meet infection-control priorities.
Competitive dynamics are influenced by after-sales service capabilities, regulatory approvals, and strategic partnerships with clinical institutions. Companies that can offer bundled packages-combining device hardware, software updates, training, and preventive maintenance-tend to strengthen procurement relationships and reduce churn. New entrants are pursuing collaborative development with clinical leaders to validate clinical outcomes and accelerate adoption, while established vendors are leveraging scale to extend distribution networks and reduce time-to-service. Across the board, intellectual property around imaging algorithms, device ergonomics, and consumable interfaces remains a key differentiator shaping R&D investment decisions.
Actionable recommendations for manufacturers, distributors, and healthcare providers to strengthen interoperability, supply resilience, and service-based commercial models
Industry leaders should prioritize interoperability, clinician-centered design, and resilient sourcing to capture value in evolving clinical markets. Investing in open architecture platforms and standardized data exchange capabilities will reduce integration friction for purchasers and increase the perceived lifetime value of devices. At the same time, product development should be informed by iterative clinical validation studies that demonstrate not only technical performance but also workflow efficiency and patient-centric outcomes.
From an operational perspective, diversifying component suppliers and expanding regional assembly options can mitigate tariff and logistics risks while shortening lead times. Commercial teams should consider expanding service contracts and subscription models to shift procurement conversations from capital expenditure toward predictable operating expense frameworks. Finally, cultivating partnerships with training institutions and specialty clinics will accelerate clinician familiarity with new technologies and foster advocacy that supports broader adoption. These strategic moves will better equip organizations to navigate regulatory complexity, procurement scrutiny, and evolving clinician expectations.
A clear description of the multi-method research methodology combining primary clinician interviews, device usability assessments, secondary regulatory and supply-chain analysis, and triangulation
The research underpinning this analysis combined qualitative and quantitative methods to ensure a robust and triangulated perspective. Primary inputs included structured interviews with clinical end users across ambulatory surgical centers, dental clinics, hospitals, and specialty clinics; executive-level discussions with manufacturers and distributors; and hands-on usability assessments of diagnostic and surgical devices. These engagements provided insight into device performance, workflow integration, and post-sale support realities.
Secondary research encompassed peer-reviewed clinical literature, regulatory filings, product manuals, and publicly available procurement policies to construct a comprehensive view of technological capabilities and adoption constraints. Supply-chain mapping was performed using trade flow data and vendor disclosures to assess sourcing dependencies and tariff exposure. Wherever possible, findings were validated through multiple independent sources and cross-checked with clinician feedback to ensure practical relevance and factual accuracy. This layered methodology supports conclusions grounded in observed practice rather than speculative assumptions.
Concluding synthesis that ties technological innovation, commercial responses, and supply-chain dynamics into a cohesive outlook for dental diagnostics and surgical equipment
The trajectory of dental diagnostic and surgical equipment is defined by a convergence of precision imaging, minimally invasive procedural platforms, and digital restorative workflows that collectively improve clinical decision-making and patient experience. Technological advances are enabling clinicians to deliver more predictable outcomes with streamlined processes, while commercial and regulatory dynamics are reshaping how products are sourced, serviced, and financed. Stakeholders who adapt to these trends by prioritizing interoperability, flexible procurement options, and clinician education will be better positioned to translate innovation into routine practice.
Looking ahead, sustained attention to supply-chain resilience, user-driven product design, and service-oriented commercial models will determine which organizations emerge as preferred partners for healthcare providers. The combined influences of regional variability, tariff-driven sourcing realignments, and rapid technology iteration underscore the need for strategic agility and evidence-based product positioning. In sum, informed investment in the right mix of technology, service, and regional strategy will be decisive for entities seeking to lead in dental diagnostics and surgery.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
195 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. AI-powered intraoral scanners enable real-time cavity detection and predictive treatment planning
- 5.2. Integration of 3D-printing surgical guides with patient-specific anatomical modeling for precision surgery
- 5.3. Adoption of photon-counting cone-beam CT for higher-resolution dental imaging at reduced radiation doses
- 5.4. Deployment of robotic-assisted implant systems for minimally invasive and guided dental surgeries
- 5.5. Development of portable salivary biomarker analyzers for chairside oral disease diagnostics
- 5.6. Advancements in tele-dentistry platforms with remote imaging and AI-based diagnostic support
- 5.7. Use of biodegradable composite materials in bone grafts to improve healing and reduce secondary procedures
- 5.8. Implementation of intraoperative fluorescence guidance for enhanced visualization of oral lesions during surgery
- 5.9. Integration of wearable sensor technology for continuous monitoring of post-operative dental implant healing
- 5.10. Expansion of augmented reality systems to assist clinicians in real-time endodontic and surgical procedures
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Dental Diagnostic & Surgical Equipment Market, by Type
- 8.1. Diagnostic
- 8.1.1. CBCT Systems
- 8.1.2. Intraoral Cameras
- 8.1.3. Ultrasound Devices
- 8.1.4. X-Ray Imaging Systems
- 8.2. Surgical
- 8.2.1. Electrosurgical Units
- 8.2.2. Laser Systems
- 8.2.3. Piezoelectric Systems
- 8.2.4. Rotary Instruments
- 9. Dental Diagnostic & Surgical Equipment Market, by Technology
- 9.1. Cad Cam Systems
- 9.1.1. Chairside Cad Cam Systems
- 9.1.2. Lab Based Cad Cam Systems
- 9.2. Imaging Systems
- 9.2.1. CBCT Systems
- 9.2.2. Intraoral Cameras
- 9.2.3. Ultrasound Devices
- 9.2.4. X-Ray Imaging Systems
- 9.3. Laser Systems
- 9.3.1. Co2 Laser Systems
- 9.3.2. Diode Laser Systems
- 9.3.3. Erbium Laser Systems
- 9.4. Ultrasonic Systems
- 10. Dental Diagnostic & Surgical Equipment Market, by Modality
- 10.1. Portable
- 10.1.1. Handheld Devices
- 10.1.2. Mobile Trolley Systems
- 10.2. Stationary
- 10.2.1. Floor Mounted Systems
- 10.2.2. Tabletop Systems
- 11. Dental Diagnostic & Surgical Equipment Market, by End User
- 11.1. Ambulatory Surgical Centers
- 11.2. Dental Clinics
- 11.3. Dental Hospitals
- 11.4. Specialty Clinics
- 12. Dental Diagnostic & Surgical Equipment Market, by Distribution Channel
- 12.1. Direct Sales
- 12.2. Hospital Distributors
- 12.3. Online Platforms
- 12.3.1. Manufacturer Websites
- 12.3.2. Third Party E Commerce
- 13. Dental Diagnostic & Surgical Equipment Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Dental Diagnostic & Surgical Equipment Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Dental Diagnostic & Surgical Equipment Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. 3M Company
- 16.3.2. A-dec, Inc.
- 16.3.3. Acteon SAS
- 16.3.4. Align Technology, Inc.
- 16.3.5. Biolase, Inc.
- 16.3.6. Coltene Holding AG
- 16.3.7. DENTSPLY SIRONA Inc.
- 16.3.8. Envista Holdings Corporation
- 16.3.9. GC Corporation
- 16.3.10. Integra LifeSciences Corporation
- 16.3.11. Ivoclar Vivadent AG
- 16.3.12. KaVo Dental GmbH
- 16.3.13. Midmark Corporation
- 16.3.14. Morita Corporation
- 16.3.15. Nakanishi Inc.
- 16.3.16. Nobel Biocare Holding AG
- 16.3.17. Patterson Dental Holdings, Inc.
- 16.3.18. Planmeca Oy
- 16.3.19. SciCan Ltd.
- 16.3.20. Straumann Holding AG
- 16.3.21. Ultradent Products, Inc.
- 16.3.22. Vatech Co., Ltd.
- 16.3.23. W&H Dentalwerk Bürmoos GmbH
- 16.3.24. Yoshida Dental Manufacturing Co., Ltd.
- 16.3.25. Young Innovations, Inc.
- 16.3.26. Zimmer Biomet Holdings, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
